These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4650643)

  • 1. The long-term use of injectable norethisterone enanthate as a contraceptive.
    el-Mahgoub S; Karim M
    Contraception; 1972 Jan; 5(1):21-9. PubMed ID: 4650643
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of medroxyprogesterone acetate employed as a long-term injectable contraceptive.
    Ringrose CA
    J Reprod Med; 1972 Feb; 8(2):75-9. PubMed ID: 4666624
    [No Abstract]   [Full Text] [Related]  

  • 3. Fertility inhibition by an injectable progestogen acting for 3 months. A clinical survey of 130 fertile women treated with norethisterone enanthate.
    Zañartu J; Navarro C
    Obstet Gynecol; 1968 May; 31(5):627-33. PubMed ID: 5651111
    [No Abstract]   [Full Text] [Related]  

  • 4. Conception control by cyclic injections of norethisterone enanthate and estradiol unducelate.
    Karim M; el-Mahgoub S
    Am J Obstet Gynecol; 1971 Jul; 110(5):740-2. PubMed ID: 5563241
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytokeratin 8, 18 and 19 in endometrial epithelium of Norplant and norethisterone enanthate injectable progestogen contraceptive users.
    Wonodirekso S; Hadisaputra W; Affandi B; Siregar B; Rogers PA
    Hum Reprod; 1996 Oct; 11 Suppl 2():144-9. PubMed ID: 8982756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term contraceptive effect of injectable progestogens: inhibition and reestabilishment of fertility.
    Zañartu J
    Int J Fertil; 1968; 13(4):415-26. PubMed ID: 4178183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of intramuscular norethisterone oenanthate used as a contraceptive on intravenous glucose tolerance and on blood coagulation factors VII and X.
    Howard G; Myatt L; Elder MG
    Br J Obstet Gynaecol; 1977 Aug; 84(8):618-21. PubMed ID: 889752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term use of depot medroxy progesterone acetate as a contraceptive.
    el-Mahgoub S; Karim M; Ammar R
    Acta Obstet Gynecol Scand; 1972; 51(3):251-5. PubMed ID: 5072160
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-acting injectable contraceptives.
    Vecchio TJ
    Adv Steroid Biochem Pharmacol; 1976; 5():1-64. PubMed ID: 779431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical study of a continuous daily micro-dose progestogen contraceptive--d-norgestrel.
    Rice-Wray E; Beristain II; Cervantes A
    Contraception; 1972 Apr; 5(4):279-94. PubMed ID: 4650653
    [No Abstract]   [Full Text] [Related]  

  • 11. Some metabolic effects of long-term use of the injectable contraceptive norethisterone oenanthate.
    Howard G; Blair M; Fotherby K; Trayner I; Hamawi A; Elder MG
    Lancet; 1982 Feb; 1(8269):423-5. PubMed ID: 6121092
    [No Abstract]   [Full Text] [Related]  

  • 12. Further study on the effect of norethisterone enanthate, an injectable contraceptive on body functions.
    Ali MN; Jalil MA
    Bangladesh Med Res Counc Bull; 1978 Dec; 4(2):63-70. PubMed ID: 575036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous low doses of clomagestone in fertility control.
    el Mahgoub S; Karim M
    J Obstet Gynaecol Br Commonw; 1971 Oct; 78(10):930-2. PubMed ID: 5111901
    [No Abstract]   [Full Text] [Related]  

  • 15. Acceptability of injectable contraceptives in Assiut, Egypt.
    Salem HT; Salah M; Aly MY; Thabet AI; Shaaban MM; Fathalla MF
    Contraception; 1988 Dec; 38(6):697-710. PubMed ID: 2975583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nor-ethisterone enanthate (SH 393) on the structure of the endometrium and on the cervical mucus.
    Achari K
    J Obstet Gynaecol India; 1969; 19(6):731-6. PubMed ID: 12255497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fertility control with norethindrone enanthate, a long-acting parenteral progestogen.
    Kesserü-Koós E; Larrañaga-Legufa A; Hurtado-Koo H; Scharff HJ
    Acta Eur Fertil; 1973 Dec; 4(4):203-21. PubMed ID: 4802108
    [No Abstract]   [Full Text] [Related]  

  • 18. Injectable contraception.
    Elder MG
    Clin Obstet Gynaecol; 1984 Dec; 11(3):723-41. PubMed ID: 6239732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Norethisterone enanthate as an injectable contraceptive in puerperal and non-puerperal women.
    Melis GB; Strigini F; Fruzzetti F; Paoletti AM; Rainer E; Düsterberg B; Fioretti P
    Contraception; 1981 Jan; 23(1):77-88. PubMed ID: 6781816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with depo-medroxyprogesterone acetate (Depo-Provera) as a contraceptive agent.
    Jeppsson S
    Acta Obstet Gynecol Scand; 1972; 51(3):257-63. PubMed ID: 5072161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.